Back to Search
PAULO HOFF, M.D.
M.D.
Medical Oncology Physician
NPI: 1891981452Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
K1475(TX)
Research & Publications (20)
A phase II study of UFT with leucovorin administered as a twice daily schedule in the treatment of patients with metastatic colorectal cancer.
PMID 18728662·Br J Cancer·2008
3-trial
A Phase I study of escalating doses of the tyrosine kinase inhibitor semaxanib (SU5416) in combination with irinotecan in patients with advanced colorectal carcinoma.
PMID 16449240·Jpn J Clin Oncol·2006
3-trial
Phase II trial of combined irinotecan and oxaliplatin given every 3 weeks to patients with metastatic colorectal cancer.
PMID 16598762·Cancer·2006
3-trial
Progress in the development of novel treatments for colorectal cancer.
PMID 15214591·Oncology (Williston Park)·2004
6-review
Oxaliplatin-related neurotoxicity: is chelation the solution?
PMID 16264824·Nat Clin Pract Oncol·2004
8-other
Monoclonal antibodies: the foundation of therapy for colorectal cancer in the 21st century?
PMID 15214593·Oncology (Williston Park)·2004
6-review
Phase I trial of combined irinotecan and oxaliplatin given every three weeks to patients with metastatic colorectal cancer.
PMID 15122078·Invest New Drugs·2004
3-trial
Phase II study of capecitabine in patients with fluorouracil-resistant metastatic colorectal carcinoma.
PMID 15169794·J Clin Oncol·2004
3-trial
Future directions in the use of antiangiogenic agents in patients with colorectal cancer.
PMID 15696026·Semin Oncol·2004
6-review
Phase I study with pharmacokinetics of S-1 on an oral daily schedule for 28 days in patients with solid tumors.
PMID 12538461·Clin Cancer Res·2003
3-trial
Phase I trial of i.v. administered tirapazamine plus cyclophosphamide.
PMID 11459995·Anticancer Drugs·2001
3-trial
Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study.
PMID 11304782·J Clin Oncol·2001
3-trial
A phase I study. Preoperative UFT/leucovorin and radiation therapy in rectal cancer.
PMID 11098495·Oncology (Williston Park)·2000
3-trial
Novel therapeutic approaches for metastatic colorectal cancer.
PMID 11195413·Oncology (Williston Park)·2000
6-review
Phase II study of intravenous CI-958 in metastatic colorectal adenocarcinoma.
PMID 11202806·Am J Clin Oncol·2000
3-trial
Combined modality treatment of locally advanced breast carcinoma in elderly patients or patients with severe comorbid conditions using tamoxifen as the primary therapy.
PMID 10813717·Cancer·2000
8-other
Phase I study of preoperative oral uracil and tegafur plus leucovorin and radiation therapy in rectal cancer.
PMID 11032595·J Clin Oncol·2000
3-trial
The tegafur-based dihydropyrimidine dehydrogenase inhibitory fluoropyrimidines, UFT/leucovorin (ORZEL) and S-1: a review of their clinical development and therapeutic potential.
PMID 11081569·Invest New Drugs·2000
6-review
Shape coexistence near neutron number N=20: first identification of the E0 decay from the deformed first excited Jpi=0+ state in 30Mg.
PMID 19659139·Phys Rev Lett·2009
8-other
Model-based prediction of phase III overall survival in colorectal cancer on the basis of phase II tumor dynamics.
PMID 19636014·J Clin Oncol·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1515 HOLCOMBE BLVD, 77030-4009
HOUSTON, TX 77030 - Phone
- (713) 792-6161
Quick Facts
- NPI
- 1891981452
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile